๐ฐ Pcr News
Page 10 - Pcr News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Pcr. Real-time updates on events, politics, business and more.
November 18, 2023
The latest effort by the city of Minneapolis to impose civilian oversight of police misconduct so far has little to show for it. In its first six months, the Community Commission on Police Oversight has handled only two cases out of the hundreds of complaints filed with the police department and the Office of Police Conduct Review (OPCR). A city website that's supposed to keep citizens ...
November 10, 2023
Dublin, Nov. 10, 2023 (GLOBE NEWSWIRE) -- The
November 8, 2023
Discussions about the competition continued at this week’s EPCR Club Conference.
November 5, 2023
JK Tyre Chairman and MD, Raghupati Singhania expects the domestic tyre demand will remain strong due to the automobile industrys growth and a positive economic environment. The companys consolidated net profit surged five-fold to Rs 249 crore in the September quarter, largely due to its strong performance in the domestic market.
November 3, 2023
A small trial has helped to further identify women who can safely skip surgery after neoadjuvant therapy for early breast cancer.
November 1, 2023
An ideal medicine for one person may prove ineffective or harmful for someone else, and predicting who could benefit from a given drug has been difficult.
October 26, 2023
Scientists find better ways to tackle the threat of invasive fungal disease with the QIAGEN nanoplate-based dPCR system for sensitive diagnostics
October 25, 2023
Scientists find better ways to tackle the threat of invasive fungal disease with the QIAGEN nanoplate-based dPCR system for sensitive diagnostics
October 23, 2023
Two randomized trials highlighted the benefit of adding immune checkpoint inhibitors to neoadjuvant chemotherapy in patients with early high-risk estrogen receptorโpositive, HER2-negative breast cancer.
October 23, 2023
The Michelangelo trial revealed that adding atezolizumab to nab-paclitaxel and carboplatin did not improve 5-year event-free survival in patients with triple-negative breast cancer.